Code de la Santé Publique — French Public Health Code

Overview

The Code de la Santé Publique (CSP) is the primary French legislative framework governing all aspects of public health, healthcare organisation, medical practice, and health data. For open neuroscience and biomedical research, the most relevant provisions are those regulating health data access, biobanking, clinical research, and patient consent — the legal layer underlying operational frameworks like Health Data Hub and EHDS.

The CSP is the domestic legal framework that operates alongside several European regulations, including the Clinical Trials Regulation (EU 536/2014) and GDPR provisions for health data. France transposed clinical research requirements through the loi Jardé (2012), which was adopted before EU 536/2014 but has been progressively aligned with it. The CSP operates alongside the Règlement Général sur la Protection des Données (RGPD/GDPR) and the Loi Informatique et Libertés (LIL) for data protection.

Key Provisions Relevant to Open Neuroscience

Health Data Access (Articles L. 1460-1 ff.)

The SNDS provisions — consolidated by the loi du 24 juillet 2019 relative à l’organisation et la transformation du système de santé — establish the legal basis for Health Data Hub operations, including conditions for secondary use of health data for research, requirement for CNIL authorisation for health data processing, and the MR (Méthodologies de Référence) system.

Biobanking (Articles L. 1243-3 ff.)

Legal framework for collections of biological samples (biobanques): authorisation requirements for biobank operation, consent requirements for biological sample collection and use, and conditions for international sample transfer.

Clinical Research (Articles L. 1121-1 ff. — loi Jardé)

The loi Jardé (2012, fully implemented 2017) framework for research involving human subjects distinguishes three categories. Catégorie 1 covers interventional research with risk above minimal (full RCP approval). Catégorie 2 covers interventional research with minimal risk (simplified approval). Catégorie 3 covers non-interventional and observational research (CNIL/IRB declaration).

Informed consent requirements for data and sample collection, right to object to use of medical records for research (opt-out mechanisms), and conditions for waiving individual consent in retrospective studies (under CNIL reference methodologies such as MR-007 for non-interventional studies).

Operational Interface with Open Science

The CSP creates the legal constraints within which French open science infrastructure operates: Health Data Hub data access is governed by CSP Articles L. 1460-1 ff.; OPIDoR JurisDoR legal resource centre interprets CSP requirements for research data management; EHDS secondary use rights (from 2029) will modify and complement existing CSP provisions under EU primacy.

Connections

Resources